CHEMED CORP Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2010 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Chemed Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2024.
- Chemed Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$5.42M, a 69.7% decline year-over-year.
- Chemed Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$8.03M, a 154% decline from 2022.
- Chemed Corp annual Deferred Income Tax Expense (Benefit) for 2022 was $14.8M, a 518% increase from 2021.
- Chemed Corp annual Deferred Income Tax Expense (Benefit) for 2021 was $2.4M, a 67.5% increase from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)